✦ LIBER ✦

The three main stumbling blocks for anticancer T cells

✍ Scribed by Lukas Baitsch; Silvia A. Fuertes-Marraco; Amandine Legat; Christiane Meyer; Daniel E. Speiser

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The linking of anticancer drugs, cell cy

✍ Richard D. Dinnen; Kaney Ebisuzaki 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Cytotoxicity of the anticancer drug doxo

✍ Kozhukharova, I. V.; Grinchuk, T. M.; Pugovkina, N. A.; Kovaleva, Z. V.; Aleksee 📂 Article 📅 2013 🏛 Pleiades Publishing 🌐 English ⚖ 380 KB

The anticancer agent adriamycin can be a

✍ Triton, T.; Yee, G 📂 Article 📅 1982 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 779 KB

Do OKT 3 monoclonal antibodies inhibit T

✍ Tor Lea 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Soluble CD4 blocks the infectivity of di

✍ Clapham, Paul R.; Weber, Jonathan N.; Whitby, Denise; McIntosh, Kenneth; Dalglei 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

T cell-depleted autologous hematopoietic

✍ Burt, R K; Traynor, A E; Cohen, B; Karlin, K H; Davis, F A; Stefoski, D; Terry, 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB